Diskussionsleiter: C. Mewis (München)
| (P1036) | Positive Extrakardiale „Pleotrophe Effekte“ durch die Parasympathikusdenervation unter der Pulmonalvenenisolation bei Vorhofflimmern | |
| M. Zarse, F. Hasan, B. Lemke, D. Mijic, Q. S. Nguyen, J. Teichmann, H. Bogossian (Witten, Lüdenscheid) | ||
| (P1037) | Evaluation and impact of a new lowest-dose imaging protocol on X-ray dose exposure in electrophysiology procedures | |
| F. Bourier, T. Reents, S. Ammar-Busch, V. Semmler, C. Lennerz, M. Kottmaier, M. Kornmayer, C. Kolb, G. Heßling, I. Deisenhofer (München) | ||
| (P1038) | Choice of AF treatment in the elderly population – a retrospective, single-center analysis | |
| M. Koch, J. Weidle, J. Siebermair, S. Sattler, K. Rizas, S. Clauß, M. F. Sinner, S. Fichtner, H. L. Estner, S. Kääb, R. Wakili (München) | ||
| (P1039) | Safe electrophysiologic profile of the potential novel antiarrhythmic drug antazoline | |
| G. Frommeyer, C. Ellermann, M. Sterneberg, S. Kaese, F. Reinke, H. Bogossian, P. Milberg, L. Eckardt (Münster, Lüdenscheid) | ||
| (P1040) | Impact of n-3 PUFA lipid mediators on atrial fibrillation in patients with chronic heart failure: the MONARCH study | |
| L. Albert, P. Lacour, W.-H. Schunck, P. L. Dang, D. A. Morris, M. Huemer, A. Wutzler, L.-H. Boldt, P. Attanasio, A. S. Parwani, B. Pieske, W. Haverkamp, F. Blaschke (Berlin, Bochum) | ||
| (P1041) | Colchicine increases ventricular vulnerability in an experimental whole-heart model | |
| G. Frommeyer, J. Krawczyk, S. Kochhäuser, S. Kaese, N. Bögeholz, C. Pott, D. Dechering, L. Eckardt (Münster) |